UMR9187 / U1196 – Chemistry and Modelling for the Biology of Cancer (CMBC)

Biotech – ABIVAX

The start-up Splicos has been created in 2008 and licensed patents co-filed by Institut Curie. These patents deal with the inhibition of alternative splicing with small molecules. Since 2009, the medicinal chemistry of this start-up is performed in the unit through a collaborative agreement and the hosting of two employees Romain Najman and Pauline Fornarelli. The start-up, called Abivax since 2014, is currently carrying out phase IIa clinical trials.

abivaxFor more information